Preliminary Third Quarter 2013 Revenue Results in Advance of Attendance at the 28th Annual North American Spine Society (NASS)

Preliminary Third Quarter 2013 Revenue Results in Advance of Attendance at the
28th Annual North American Spine Society (NASS) Meeting in New Orleans,

Continuing Execution Propels Alphatec to Strong Third Quarter Global Growth

CARLSBAD, Calif., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that provides physician-inspired solutions for patients with spinal
disorders, today announced its top line financial results for the third
quarter of fiscal year 2013, ended September 30, 2013.

Third Quarter Revenue Highlights include:

  *Third quarter 2013 total revenue is approximately $50.1 million; up
    approximately 7.0% from the third quarter of 2012, or approximately 10.0%
    on a constant currency basis, representing broad growth in all of our
  *U.S. revenue of approximately $33.7 million; up approximately 8.8% from
    the third quarter of 2012. Positive performance in the U.S. was the result
    of continued solid unit volume gains in our core hospital business and
    increased surgeon uptake across our various product lines.
  *International revenue is approximately $16.4 million; up approximately
    3.4% from the third quarter of 2012, or approximately 13.0% on a constant
    currency basis. Strong operational performance was again attributable to
    the Company's robust business in Japan combined with thriving underlying
    demand in Latin America, Asia and Europe.

Alphatec Spine expects to file a more detailed press release regarding its
third quarter 2013 results on Form 8-K as well as filing its Form 10-Q for the
three months ended September 30, 2013 on November 7, 2013, with an
accompanying investor call to follow shortly thereafter.

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
physician-inspired products and solutions for the treatment of spinal
disorders associated with trauma, congenital deformities, disease and
degeneration. The Company's mission is to combine innovative surgical
solutions with world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors.

Additional information can be found at

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward looking
statements. Alphatec Spine cautions investors that there can be no assurance
that actual results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as a result of
various factors. Forward looking statements include references to Alphatec
Spine's 2013 revenue (including without limitation, the approximated revenues
for Q3 2013 that are set forth in this press release) and adjusted EBITDA
projections; the success of the Company's initiatives to drive global sales
growth, increase margins and increase operating efficiencies. The words
"believe," "will," "should," "expect," "intend," "estimate," "anticipate," and
"approximately" and variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a statement
is not a forward-looking statement. Please refer to the risks detailed from
time to time in Alphatec Spine's SEC reports, including its Annual Report Form
10-K for the year ended December 31, 2012, filed on March 4, 2013 with the
Securities and Exchange Commission, as well as other filings on Form 10-Q and
periodic filings on Form 8-K. Alphatec Spine disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise, unless required by

CONTACT: Investor/Media Contact:
         Christine Zedelmayer
         Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610

Alphatec Spine
Press spacebar to pause and continue. Press esc to stop.